Abstract
Synthetic cannabinomimetic compounds present unique challenges for both healthcare professionals and lawmakers. A case of a 16-year-old girl who had been admitted to John Hunter Hospital as a result of a psychosis after ingestion of a synthetic cannabinomimetic and other drugs prompted the review of a range of hitherto unanticipated legislative and drug policy issues for consideration of healthcare professionals. The challenges and options open to legislators and law enforcement agencies to deal with synthetic cannabinomimetics and other ‘legal’ synthetic compounds that mimic illicit drugs for recreational use, such as ‘legal’ heroin, cocaine or lysergic acid diethylamide, are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
